Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction.

By G. Marenzi, G. Lauri, E. Assanelli, J. Campodonico, M. De Metrio, I. Marana, M. Grazi, F. Veglia, A. Bartorelli. Journal of the American College of Cardiology, 2004

756 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Critical Care and Intensive Care Medicine, Nephrology

View Paper: https://www.semanticscholar.org/paper/5386fc064f5ab1ba35ec23088e2305d42fb568c8

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. F. Stacul
2. A. Molen
3. R. Mehran
4. P. Reimer
5. E. Nikolsky
6. J. Webb
7. H. Thomsen
8. A. Cabiati

Citations in the corpus

• Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines (2011, background): “Also, a large number of studies have showed that mortality, both during hospitalisation and at 1 year, is significantly increased in the patients who developed CIN [22, 24, 25, 31, 32].”
• Contrast-induced nephropathy (2012, background): “Patients undergoing primary angioplasty for ST-elevation myocardial infarction (STEMI) are also at high risk for CIN [9].”
• Contrast-induced nephropathy: definition, epidemiology, and patients at risk. (2006, background): “9 The risk of CIN is especially high (19p) in the setting of primary PCI for acute myocardial infarction”